Replies to post #413717 on Amarin Corp Plc (AMRN)

[JRoon71]

It's not. This is the 2nd time HLS has materially reduced it's forward guidance of Vascepa sales.

And they indicated that part of the issue is lower than expected uptake by GP's (Pfizer's responsibility)

They have $8.0M YTD in Vascepa sales. Roughly 50% of that is through GP's. So Pfizer has generated roughly $4.0M in revenue for HLS for sales of Vascepa. Not exactly killing it.

And HLS is still losing money on Vascepa.

[lizzy241]

Tal, not good but they have Pfizer on their side. Their expertise is priceless, we need a BP partner. So what if they have to give up some of their margins. Grow the top line stay focused it will take a couple of years but I'm confident it will happen. It meaning a BO.

[seve333]

Given how incredibly hard it seems to generate revenue in countries outside of the USA how in the world are we going to get a BP to buy us? Approvals are great but if there is not much revenue to be had in these countries is anyone really going to be interested? Serious question.

[bidmark]

How does that compare with Vascepa uptake in the UK?